Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: A prospective, long-term study

被引:73
作者
Kristo, C [1 ]
Jemtland, R
Ueland, T
Godang, K
Bollerslev, J
机构
[1] Rikshosp Univ Hosp, Dept Med, Endocrinol Sect, N-0027 Oslo, Norway
[2] Rikshosp Univ Hosp, Dept Med, Internal Med Res Inst, N-0027 Oslo, Norway
关键词
D O I
10.1530/eje.1.02067
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Endogenous Cushing's syndrome (CS) is associated with bone loss and an increased risk of fractures. However, the long-term outcome of treatment on bone health has not been adequately clarified. Design: We followed 33 patients with active CS prospectively before and twice after treatment (mean follow-up 33 (n = 25) and 71 months (n = 18). respectively). The patients were compared to age-, sex- and body mass index (BMI)-matched controls. also followed longitudinally Methods: Bone mineral indices (bone mineral density (BMD). bone mineral content (BMC) and bone area) were evaluated in the lumbar spine (LS). femoral neck (FN). and total body (TB) by dual-energy X-ray absorptiometry (DXA). Biochemical markers of bone turnover were assessed by serum levels of osteocalcin and C-terminal telopeptides of Type-1 collagen (CTX-1). Results: Mann-Whitney rank sum tests showed that BMI) of the LS. FN and TB; was reduced by 14.8% (P < 0.001), 15.7% (P < 0.001), and 9.2% (P < 0.001) in CS vs. controls at baseline, with markedly reduced serum osteocalcin (P = 0.014) and increased CTX-1 (P = 0.012) levels. but no correlation between markers. At first follow-up, BMD was increased in LS (7.9%. P < 0.001) and FN (3.5%. P = 0.003) compared to baseline. The time-dependent rise in BMD (LS (r = 0.59: P = 0.002) and FN (r = 0.52: P = 0.007); Spearman's rank correlation), in CS was paralleled by increased osteocalcin (275%, P < 0.001) and correlation between biochemical markers (r = 0.92. P < 0.001: Pearson's correlation). TB BMD did not increase significantly before the second follow-up, when BMD Z-scores were normalized in all three compartments. Conclusion: Our observations demonstrate restoration Of coupled bone remodeling and normalization of bone mineral density in all measured skeletal compartments of treated CS patients after prolonged recovery, first significant in predominantly trabecular bone (i.e. lumbar spine).
引用
收藏
页码:109 / 118
页数:10
相关论文
共 40 条
[1]   The effects of calcitonin on bone resorption in hyperthyroidism:: a placebo-controlled clinical study [J].
Akçay, MN ;
Akçay, G ;
BIlen, H .
JOURNAL OF BONE AND MINERAL METABOLISM, 2004, 22 (02) :90-93
[2]   Diagnosis and complications of Cushing's syndrome: A consensus statement [J].
Arnaldi, G ;
Angeli, A ;
Atkinson, AB ;
Bertagna, X ;
Cavagnini, F ;
Chrousos, GP ;
Fava, GA ;
Findling, JW ;
Gaillard, RC ;
Grossman, AB ;
Kola, B ;
Lacroix, A ;
Mancini, T ;
Mantero, F ;
Newell-Price, J ;
Nieman, LK ;
Sonino, N ;
Vance, ML ;
Giustina, A ;
Boscaro, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (12) :5593-5602
[3]   Cushing's syndrome [J].
Boscaro, M ;
Barzon, L ;
Fallo, F ;
Sonino, N .
LANCET, 2001, 357 (9258) :783-791
[4]   Glucocorticoid-induced osteoporosis: Summary of a workshop [J].
Canalis, E ;
Giustina, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (12) :5681-5685
[5]   Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects [J].
Chen, QX ;
Kaji, H ;
Iu, MF ;
Nomura, R ;
Sowa, H ;
Yamauchi, M ;
Tsukamoto, T ;
Sugimoto, T ;
Chihara, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (10) :4655-4658
[6]   Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: Study in eumenorrheic patients with Cushing's syndrome [J].
Chiodini, I ;
Carnevale, V ;
Torlontano, M ;
Fusilli, S ;
Guglielmi, G ;
Pileri, M ;
Modoni, S ;
Di Giorgio, A ;
Liuzzi, A ;
Minisola, S ;
Cammisa, M ;
Trischitta, V ;
Scillitani, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (06) :1863-1867
[7]   Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome [J].
Cortet, B ;
Cortet, C ;
Blanckaert, F ;
d'Herbomez, M ;
Marchandise, X ;
Wémeau, JL ;
Decoulx, M ;
Dewailly, D .
OSTEOPOROSIS INTERNATIONAL, 2001, 12 (02) :117-123
[8]   Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease [J].
Di Somma, C ;
Colao, A ;
Pivonello, R ;
Klain, M ;
Faggiano, A ;
Tripodi, FS ;
Merola, B ;
Salvatore, M ;
Lombardi, G .
CLINICAL ENDOCRINOLOGY, 1998, 48 (05) :655-662
[9]   Severe impairment of bone mass and turnover in Cushing's disease: comparison between childhood-onset and adulthood-onset disease [J].
Di Somma, C ;
Pivonello, R ;
Loche, S ;
Faggiano, A ;
Marzullo, P ;
Di Sarno, A ;
Klain, M ;
Salvatore, M ;
Lombardi, G ;
Colao, A .
CLINICAL ENDOCRINOLOGY, 2002, 56 (02) :153-158
[10]   Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study [J].
Di Somma, C ;
Pivonello, R ;
Loche, S ;
Faggiano, A ;
Klain, M ;
Salvatore, M ;
Lombardi, G ;
Colao, A .
CLINICAL ENDOCRINOLOGY, 2003, 58 (03) :302-308